OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance
Shaun Ye Song Tan, Aaron Mingyang Yee, Jackie Jia Lin Sim, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 5, pp. 1757-1772
Open Access | Times Cited: 21

Showing 21 citing articles:

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, et al.
Annals of the Rheumatic Diseases (2023) Vol. 83, Iss. 1, pp. 15-29
Open Access | Times Cited: 330

Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations
Myrto Kostopoulou, Chetan Mukhtyar, George Βertsias, et al.
Annals of the Rheumatic Diseases (2024), pp. ard-225319
Open Access | Times Cited: 7

Self‐Reported Delayed Adverse Events and Flare Following COVID‐19 Vaccination Among Patients With Autoimmune Rheumatic Disease (AIRD) in Malaysia: Results From the COVAD‐2 Study
Syahrul Sazliyana Shaharir, Azmawati Mohammed Nawi, Theepa Nesam Mariamutu, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access

Analysis of related factors for systemic lupus erythematosus flare after SARS‐Cov‐2 infection: A retrospective cohort study
Qian Li, Junkang Zhao, Junyan Zhang, et al.
International Journal of Rheumatic Diseases (2025) Vol. 28, Iss. 1
Closed Access

Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study
Natália Sarzi Sartori, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 127-127
Open Access

Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus
Nuntawan Piyaphanee, Sirirat Charuvanij, Sutheera Thepveera, et al.
Lupus (2024) Vol. 33, Iss. 5, pp. 450-461
Closed Access | Times Cited: 4

Systemic Lupus Erythematosus and COVID-19
Μαρία Παππά, Alexandros Panagiotopoulos, Κonstantinos Thomas, et al.
Current Rheumatology Reports (2023) Vol. 25, Iss. 10, pp. 192-203
Open Access | Times Cited: 11

Systemic Lupus Erythematosus and Cytokine Storm
Roberto Caricchio, Stefania Gallucci
Advances in experimental medicine and biology (2024), pp. 355-364
Closed Access | Times Cited: 3

Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
R Naveen, Elena Nikiphorou, Mrudula Joshi, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 7, pp. 2453-2463
Open Access | Times Cited: 15

Delphi Panel Consensus Statement Generation: COVID-19 Vaccination Recommendations for Immunocompromised Populations in the European Union
Jaya Paranilam, Francesco Arcioni, Antonio Franco, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 11, pp. 2227-2253
Open Access | Times Cited: 1

The Impact of The COVID-19 Pandemic On SLE
Xingwang Zhao, Haohao Wu, Shifei Li, et al.
Modern Rheumatology (2023)
Open Access | Times Cited: 4

Cutaneous adverse reactions associated with COVID-19 vaccines: Current evidence and potential immune mechanisms
Po‐Chien Wu, Wan‐Chen Lin, Chuang‐Wei Wang, et al.
Clinical Immunology (2024) Vol. 263, pp. 110220-110220
Open Access

COVID-19 Vaccine Effectiveness among Patients with Psoriatic Disease: A Population-Based Study
Tal Gazitt, Lihi Eder, Walid Saliba, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 453-453
Open Access

Seguridad de la vacunación COVID-19 en una muestra de pacientes brasileños con lupus eritematoso sistémico
Bianca Lins Alencar, Valentina Busato, Renato Nisihara, et al.
Revista Argentina de Reumatología (2024) Vol. 35, Iss. 1, pp. 11-16
Open Access

Favourable humoral but reduced cellular immune response to COVID-19 mRNA BNT162b2 vaccine in patients with childhood-onset systemic lupus erythematosus
Esra Karabağ Yılmaz, Ayşe Ağbaş, Nur Canpolat, et al.
Lupus Science & Medicine (2024) Vol. 11, Iss. 2, pp. e001268-e001268
Open Access

Interventions to Improve COVID-19 Vaccine Hesitancy
Nnenna Ezeh, Taussia Boadi, Maria I. Danila, et al.
Rheumatic Disease Clinics of North America (2024) Vol. 51, Iss. 1, pp. 61-73
Closed Access

COVID‐19 Vaccination in Patients With Systemic Lupus Erythematosus: Adverse Events and Rating Agreement of Flares Between Patients and Physicians
Punsita Tangkum, Nuntana Kasitanon, Wanitcha Gumtorntip, et al.
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 12
Closed Access

Flares and Predicting Factors of Flares in Patients with Systemic Lupus Erythematosus Associated with Different Doses and Types of COVID-19 Vaccines
Worawit Louthrenoo, Punsita Tangkum, Nuntana Kasitanon, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1399-1399
Open Access

Clinical and radiological evaluation of systemic lupus erythematosus, Research question: Evaluation of lupus cases in corona infection
Khalid khattab, MOHAMAD AL AYED, ABDUL MAJD AL SHWEIKI, et al.
Research Square (Research Square) (2024)
Open Access

The Role of Sinopharm BIBP COVID-19 Vaccine Immunization in Systemic Lupus Erythematous Flare-up
Parisa Delkash, Amir Azimi, Niloufar Taherpour, et al.
Archives of Clinical Infectious Diseases (2023) Vol. 18, Iss. 5
Open Access | Times Cited: 1

Page 1

Scroll to top